Smartkarma Originals
Asian Healthcare - Coming of Age
This Smartkarma Originals Insight highlights 20 leading unlisted healthcare companies in Asia, mainly in digital healthcare and biopharma, that are...
885 Views
GDS Holdings HK Secondary Trading- Strong Coverage but No Discount and Volatile Markets Won't Help
Gds Holdings (Adr) (GDS US) raised around US$1.6bn in its secondary listing in Hong Kong. In this note, I'll talk about the deal dynamics and...
371 Views
New Oriental Hong Kong Secondary - Might Be Relatively Small
New Oriental Education (EDU US) plans to raise around US$1bn in its secondary listing in Hong Kong. While the company has filed its PHIP, the exact...
276 Views
What HKEX Biotech "Step-Ups" Can Tell Us
This Insight explains the concept of valuation "step-ups" for pre-revenue biotechnology companies listing on the HKEX and how to use this data to...
343 Views
GDS Holdings Hong Kong Secondary - Going Big. Will Almost Become Net Cash, for a While.
Gds Holdings (Adr) (GDS US) plans to raise around US$1.6bn in its secondary listing in Hong Kong. I had covered the background of the deal in my...
297 Views